Literature DB >> 11114737

The contradictions of the insulin-like growth factor 1 receptor.

R Baserga1.   

Abstract

In recent years, the type 1 insulin-like growth factor receptor (IGF-IR) has emerged as a receptor that plays a very important role in the growth of cells, both in vivo and in vitro. The ability of the IGF-IR to induce mitogenesis and to promote survival of cells against a variety of apoptotic agents is well documented. Somewhat less known are other functions of the IGF-IR, like its ability to induce differentiation, to regulate cell size and to affect the organization of the cytoskeleton of cells. This review will focus on these lesser known functions of the IGF-IR. At the same time, we will emphasize how the IGF-IR can send contradictory signals, which depend on different domains of the receptor and the availability of downstream transducing molecules.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11114737     DOI: 10.1038/sj.onc.1203854

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  74 in total

Review 1.  Insulin like growth factor-1 and insulin-like growth factor binding proteins: their possible roles in both maintaining normal retinal vascular function and in promoting retinal pathology.

Authors:  Lynn C Shaw; Maria B Grant
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

2.  The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase.

Authors:  Matthew J Martin; Nataliya Melnyk; Michelle Pollard; Mary Bowden; Hon Leong; Thomas J Podor; Martin Gleave; Poul H B Sorensen
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

3.  Decorin differentially modulates the activity of insulin receptor isoform A ligands.

Authors:  Alaide Morcavallo; Simone Buraschi; Shi-Qiong Xu; Antonino Belfiore; Liliana Schaefer; Renato V Iozzo; Andrea Morrione
Journal:  Matrix Biol       Date:  2014-01-02       Impact factor: 11.583

Review 4.  Critical signal transduction pathways in CLL.

Authors:  Asish K Ghosh; Neil E Kay
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 5.  Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

Review 6.  MicroRNAs in the human pituitary.

Authors:  Milani Sivapragasam; Fabio Rotondo; Ricardo V Lloyd; Bernd W Scheithauer; Michael Cusimano; Luis V Syro; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2011-09       Impact factor: 3.943

7.  Cell-specific effects of insulin receptor substrate-1 deficiency on normal and IGF-I-mediated colon growth.

Authors:  J G Simmons; Y Ling; H Wilkins; C R Fuller; A J D'Ercole; James Fagin; P K Lund
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-09-06       Impact factor: 4.052

8.  IGFBP-rP1, a potential molecule associated with colon cancer differentiation.

Authors:  Wenjing Ruan; Shuzhen Zhu; Haibing Wang; Fangying Xu; Hong Deng; Yu Ma; Maode Lai
Journal:  Mol Cancer       Date:  2010-10-26       Impact factor: 27.401

9.  Molecular targeted therapy in advanced renal cell carcinoma: A review of its recent past and a glimpse into the near future.

Authors:  John S P Yuen
Journal:  Indian J Urol       Date:  2009 Oct-Dec

10.  Gq-coupled purinergic receptors inhibit insulin-like growth factor-I/phosphoinositide 3-kinase pathway-dependent keratinocyte migration.

Authors:  Salma Taboubi; Françoise Garrouste; Fabrice Parat; Gilbert Pommier; Emilie Faure; Sylvie Monferran; Hervé Kovacic; Maxime Lehmann
Journal:  Mol Biol Cell       Date:  2010-01-20       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.